drugset / Trial / NCT01613586
A Randomized Study Comparing Placebo and ASP3652 in the Treatment of Women With Bladder Pain Syndrome / Interstitial Cystitis (BPS/IC)
RandomizedParallel-groupQuadruple-blindTreatment
Summary
In this study several dose levels of ASP3652, given orally for 12 weeks, will be compared with placebo in the treatment of female patients with Bladder Pain Syndrome / Interstitial Cystitis.
Timeline
- Start
- 2012-05-31
- Primary completion
- 2014-03-18
- Completion
- 2014-03-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ASP3652 | Unknown | 50 mg | Oral |
| Subject | ASP3652 | Unknown | 150 mg | Oral |
| Subject | ASP3652 | Unknown | 300 mg | Oral |